Key Market Segments
By Type
-
DNA Chips
-
Lab-On-A-Chip
-
Protein Chips
By Technology
-
Microarrays
-
Microfluidics
By End-User
-
Biotechnology and Pharmaceutical Companies
-
Hospitals
-
Diagnostics Centers
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The biochips market is valued at USD 14.58 billion in 2025 and is projected to reach USD 36.31 billion by 2033, growing at a CAGR of 12.09%.
Biochips Market growth is driven by advancements in personalized medicine, rising chronic disease prevalence, and increasing adoption of high-throughput and point-of-care diagnostic technologies
DNA chips dominate the market with a 38.77% share in 2025, while lab-on-a-chip is the fastest-growing segment.
North America leads the global biochips market with a 43.20% revenue share, supported by strong R&D infrastructure and advanced healthcare systems.
Key players include Thermo Fisher Scientific, Illumina, Agilent Technologies, Bio-Rad Laboratories, and QIAGEN N.V.